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Thrombosis in myocardial infarction and unstable angina. 
Over the past 2 decades, a clearer understanding of the acute 
coronary syndromes has resulted in important progress in 
management strategies for atherosclerotic coronary artery 
disease. Whereas short- and longer-term prognosis in pa- 
tients with acute myocardial infarction was found to relate to 
differing magnitudes of ventricular dysfunction (I), no com- 
mon consensus as to the precipitating cause or causes was 
reached. In particular, a primary role for thrombosis was 
widely questioned (2). However, in 1980, the angiographic 
study by DeWood et al. (3) of patients with clinical myocar- 
dial infarction admitted for acute surgical revascularization 
demonstrated that 86% of patients who underwent cardiac 
catheterization within the first 4 h of symptom onset had 
diseased coronary arteries completely occluded by recent 
thrombus. These observations have been confirmed widely 
to allow for the general conclusion that acute myocardial 
infarction is due to a completely obstructive thrombus in a 
previously diseased coronary artery with, after an interval of 
0.5 to 6 h, myocardial necrosis in the territory subserved by 
this vessel. This demonstration has provided a logical basis 
for current therapies providing acute coronary revascular- 
ization by injection or infusion of thrombolytic agents or by 
mechanical means. 
Thrombosis has ulso been demonstrated in another rela- 
tively well defined acute syndrome-unstable angina pec- 
toris (4). Intraoperative angioscopic examination revealed 
intravascular ulceration with nonobstructive thrombus in 
patients with this clinical syndrome who had not responded 
to medical therapy (5). In contrast, patients operated on for 
severe but stable angina pectoris had an intact endothelial 
lining, even at the point of maximal luminal reduction, 
without observable thrombus. Patients categorized as having 
“unstable angina” must have a minimal level of blood flow 
through the culprit artery or collateral vessels, allowing for 
viability in the territory of distribution, thus providing a 
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negative serum enzyme test. A majority of patients studied 
weeks or months after completed acute myocardial infarc- 
tion demonstrated patency of the culprit artery (6). Total 
coronary occlusion must have existed in these patients with 
transmural necrosis, yet later recanalization due to sponta- 
neous thrombolysis had taken place. Ip these earlier reports 
of patients with acute transmural infarction or patients with 
unstable angina, thrombolytic agents or platelet inhibitors 
were not used, althou@ some patients had received heparin. 
The vascular pathology of atherosclerosis. This is complex 
and variable (7) and from time to time results in endothelial 
ulceration with exposure of the subendothelial material to 
flowing blood. Cholesterol, collagen, fibrous tissue, calcifi- 
cation--the lipid gruel-all affect the interaction between the 
exposed atherosclerotic lesion and blood components (8). 
Liberation of tissue thromboplastin and activation of plate- 
lets at the site of tissue damage are rapid. Absence of normal 
functioning endothelium results in a variety of effects, in- 
cluding the induction of thromboses and vasoconstriction, 
which tends to cause further obstruction in an already partly 
obstructed vessel. Primary thrombus forming deep fissures 
within the plaque itself (9) may prove to be resistant to lysis 
and favor formation of secondary thrombus, extending into 
the lumen of the vessel, that may be more susceptible to 
natural or induced lysis. A balance exists in which natural 
lytic substances ordinarily first oppose and then overcome 
the thrombotic processes and prothrombotic factors with 
plaque remodeling and final healing with endothelial repair. 
The severity of stable obstruction by the atherosclerotic 
lesion may be greater or less than that before ulceration (10). 
Acute coronary syndromes. These vary widely in their 
clinical presentation and acute myocardial infarction proba- 
bly represents a distinct minority of events. The majority- 
unstable angina, prolonged myocardial ischemia and “ruled 
out” myocardial infarction-are by definition not associated 
with myocardial necrosis (negative serum enzymes) and are 
consistent with the concept of timely and effective sponta- 
neous lysis of a partial or even completed thrombotic occlu- 
sion. Thus, unstable angina may represent a situation in 
which thrombotic occlusion is severe but does not progress 
to completion; in “prolonged myocardial ischemia,” chest 
pain and T wave changes persist beyond those that are usual 
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in angina (I 1). Patients with “ruled out” myocardial infarc- 
tion are characterized by even more prolonged or persistent 
pain and T wave abnormalities of greater magnitude, and 
they require in-hospital observation, normalization of the 
electrocardiogram and a negative enzyme test before cate- 
gorization and discharge. However, 70% of such patients 
have important coronary artery disease. A significant pro- 
portion of patients with acute myocardial infarction not 
receiving thrombolytic agents or beta-adrenergic blockade 
demonstrated evidence for spontaneous reperfusion (12). 
Even in sudden death syndrome, angiographic studies per- 
formed on survivors have implicated plaque rupture, throm- 
bosis and spontaneous lysis (13,14). 
Spontaneous thromholysis and reperfusion. In each of 
these syndromes, a rational model of complete coronary 
occlusion rapidly relieved by intrinsic thrombolytic mecha- 
nisms or by mechanical displacement due to a significant 
pressure gradient across the area of atherosclerosis is con- 
sistent with these facts and current knowledge. In unstable 
angina, occlusion is severe (or perhaps complete) but un- 
commonly persists for more than a very few minutes. 
Spontaneous reperfusion occurs in ~20 min in “prolonged 
myocardial ischemia,” in 30 to 40 min in “ruled out” 
myocardial infarction, in 60 to 90 min in “non-Q wave 
infarction” (a syndrome not dissimilar to induced throm- 
bolysis) and for ~3 h in acute transmural myocardial infarc- 
tion. As described (6), even in conventionally treated acute 
transmural myocardial infarction, late spontaneous lysis 
takes place in a significant proportion of patients including 
those with ventricular aneurysm (15). 
Reexamination of the placebo data from the various trials 
of thrombolytic agents in acute myocardial infarction sup- 
ports this contention, In one study (16), reperfusion was 
demonstrated in >70% of patients who underwent catheter- 
ization 7 to 10 days after assignment to placebo or nitroglyc- 
erin while receiving anticoagulant therapy. In another study 
(17), the angiographic patency in patients receiving placebo 
with aspirin was 55% at 30 days. 
Thus, extensive myocardial necrosis in the clinical syn- 
drome of acute myocardial infarction can be attributed to 
failure of timely spontaneous lysis. A reasonable estimate 
indicates that the number of patients with “ruled out” and 
“non-Q wave” infarction discharged from coronary care 
units is three times the number of patients discharged with 
“transmural” myocardial infarction. Unstable angina, pro- 
longed ischemia and “ruled out myocardial infarction” with 
enzyme values within normal limits are more frequent than is 
non-Q or Q-wave infarction. Thus, spontaneous lysis must 
be the rule in acute thrombolytic coronary syndromes, 
perhaps by a factor of five or greater. Persistent thrombotic 
occlusion is, in fact, the exception. 
The data supporting spontaneous lysis in the ulceration- 
thrombosis syndromes (18) appear compelling in unstable 
angina (rapid) and in acute myocardial infarction (late and 
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sometimes not at all). Data are unavailable in cases of 
prolonged myocardial ischemia. In non-Q wave infarction, 
persistent occlusion appears to be uncommon (19). In the 
latter syndrome, coronary collateral flow may limit the 
extent of myocardial damage. 
Clinical implications. The implications of this hypothesis 
are significant. First, spontaneous lytic processes are pow- 
erful biologic mechanisms that are deserving of at least as 
much investigation as pharmacologically induced lysis. Sec- 
ond, failure of spontaneous lysis may be due to overwhelm- 
ing thrombogenicity of the ulcerated intracoronary plaque 
because of size, composition, location or an inadequate 
response of lytic mechanisms. This may be due either to lack 
of elements in the lytic chain or to excess of circulating 
plasminogen activator inhibitors (20). Evidence exists for 
increased levels of fibrinogen in patients with stable coro- 
nary disease (21) and in patients with acute myocardial 
infarction (22) and for a possible relation of these increased 
levels to hyperlipidemia. Major circadian fluctuations may 
be relevant to time of onset of acute myocardial infarction 
(23). However, rt-PA rapid-inhibitor levels vary widely in 
both patients with coronary artery disease and normal con- 
trol subjects (24). 
The relation of thrombosis to coronary ulceration sod 
healing is well recognized; it is significant in the acute 
coronary syndromes (25) and possibly in nonsymptomatic 
ischemia. The purpose of this editorial is to underscore the 
usual efficacy of natural lytic processes. Why do they fail, if 
only in a minority of thrombotic coronary events? Does the 
solution lie in newer, safer lytic agents (26), prehospital 
treatment strategies (27), prevention of increases of plasmin- 
ogen activator inhibitors (20) or inhibition of the thrombo- 
genie and vasoactive consequences of vascular ulceration? 
Do other mechanisms remain to be discovered? Whatever 
the cause, persistence of thrombus resulting in myocardial 
infarction is an uncommon outcome in the acute coronary 
syndromes. 
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